 Lyle Burdine
Concepts (178)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 4 | 2022 | 188 | 1.210 |
Why?
| | DNA-Activated Protein Kinase | 4 | 2023 | 23 | 1.140 |
Why?
| | Graft Survival | 7 | 2022 | 165 | 1.020 |
Why?
| | Liver Transplantation | 6 | 2023 | 160 | 1.000 |
Why?
| | Cholecystectomy | 1 | 2021 | 32 | 0.790 |
Why?
| | Bile Ducts | 1 | 2021 | 53 | 0.770 |
Why?
| | Postoperative Care | 1 | 2021 | 121 | 0.750 |
Why?
| | Organ Transplantation | 1 | 2020 | 48 | 0.730 |
Why?
| | Patient Readmission | 1 | 2021 | 242 | 0.670 |
Why?
| | Interleukin-2 | 1 | 2017 | 75 | 0.610 |
Why?
| | Calcineurin | 1 | 2017 | 70 | 0.570 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2015 | 27 | 0.520 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2015 | 35 | 0.520 |
Why?
| | Nuclear Proteins | 1 | 2015 | 252 | 0.460 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 162 | 0.450 |
Why?
| | Proteomics | 1 | 2015 | 343 | 0.430 |
Why?
| | Tissue and Organ Procurement | 2 | 2022 | 39 | 0.390 |
Why?
| | Cold Ischemia | 2 | 2022 | 11 | 0.390 |
Why?
| | Delayed Graft Function | 2 | 2022 | 11 | 0.390 |
Why?
| | Graft Rejection | 2 | 2022 | 161 | 0.390 |
Why?
| | Peptides | 4 | 2009 | 276 | 0.370 |
Why?
| | DNA-Binding Proteins | 4 | 2021 | 462 | 0.350 |
Why?
| | Dihydroxyphenylalanine | 3 | 2006 | 6 | 0.350 |
Why?
| | Periodic Acid | 2 | 2006 | 4 | 0.330 |
Why?
| | Cross-Linking Reagents | 5 | 2008 | 42 | 0.330 |
Why?
| | Tissue Donors | 4 | 2022 | 110 | 0.300 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2008 | 170 | 0.300 |
Why?
| | Humans | 22 | 2023 | 54284 | 0.270 |
Why?
| | Phosphorylation | 2 | 2017 | 614 | 0.250 |
Why?
| | Receptors, Drug | 1 | 2004 | 6 | 0.250 |
Why?
| | Transplants | 1 | 2023 | 18 | 0.230 |
Why?
| | Transcriptional Activation | 2 | 2017 | 134 | 0.230 |
Why?
| | Repressor Proteins | 1 | 2004 | 165 | 0.230 |
Why?
| | Antibody Formation | 1 | 2022 | 69 | 0.220 |
Why?
| | Creatinine | 1 | 2022 | 169 | 0.210 |
Why?
| | Cholecystitis | 1 | 2021 | 13 | 0.210 |
Why?
| | Cholecystostomy | 1 | 2021 | 10 | 0.210 |
Why?
| | Jurkat Cells | 2 | 2021 | 34 | 0.210 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 11 | 0.210 |
Why?
| | Hospitals, Low-Volume | 1 | 2021 | 23 | 0.200 |
Why?
| | Protein Stability | 2 | 2021 | 44 | 0.200 |
Why?
| | Hospitals, High-Volume | 1 | 2021 | 35 | 0.200 |
Why?
| | Early Growth Response Protein 1 | 1 | 2021 | 39 | 0.200 |
Why?
| | Databases as Topic | 1 | 2021 | 46 | 0.200 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2021 | 24 | 0.200 |
Why?
| | Chromones | 1 | 2021 | 16 | 0.200 |
Why?
| | Retrospective Studies | 6 | 2022 | 6432 | 0.200 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 197 | 0.190 |
Why?
| | Morpholines | 1 | 2021 | 64 | 0.190 |
Why?
| | Skin Transplantation | 1 | 2021 | 50 | 0.190 |
Why?
| | Middle Aged | 6 | 2021 | 13088 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2020 | 83 | 0.180 |
Why?
| | Immunocompromised Host | 1 | 2020 | 130 | 0.180 |
Why?
| | Warm Ischemia | 1 | 2018 | 4 | 0.170 |
Why?
| | Reoperation | 1 | 2021 | 454 | 0.170 |
Why?
| | T-Lymphocytes | 1 | 2021 | 373 | 0.170 |
Why?
| | Wounds and Injuries | 1 | 2022 | 321 | 0.170 |
Why?
| | Tissue and Organ Harvesting | 1 | 2018 | 27 | 0.170 |
Why?
| | Hepatectomy | 1 | 2018 | 33 | 0.170 |
Why?
| | Operative Time | 1 | 2018 | 76 | 0.160 |
Why?
| | Central Venous Pressure | 1 | 2018 | 8 | 0.160 |
Why?
| | United States | 4 | 2022 | 5217 | 0.160 |
Why?
| | Living Donors | 1 | 2018 | 25 | 0.160 |
Why?
| | Intraoperative Care | 1 | 2018 | 57 | 0.160 |
Why?
| | NFATC Transcription Factors | 1 | 2017 | 20 | 0.160 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2017 | 45 | 0.150 |
Why?
| | End Stage Liver Disease | 1 | 2018 | 43 | 0.150 |
Why?
| | Female | 8 | 2023 | 28441 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 136 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2018 | 138 | 0.150 |
Why?
| | Oligopeptides | 1 | 2017 | 95 | 0.150 |
Why?
| | Renal Dialysis | 1 | 2018 | 192 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 183 | 0.140 |
Why?
| | Kidney Failure, Chronic | 1 | 2018 | 231 | 0.140 |
Why?
| | Male | 6 | 2021 | 27334 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 573 | 0.130 |
Why?
| | Gene Expression | 1 | 2017 | 664 | 0.130 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1300 | 0.120 |
Why?
| | Indoles | 1 | 2015 | 289 | 0.110 |
Why?
| | DNA | 3 | 2023 | 581 | 0.110 |
Why?
| | Death | 2 | 2022 | 22 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 866 | 0.100 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 1550 | 0.100 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 368 | 0.090 |
Why?
| | Aged | 2 | 2021 | 10054 | 0.090 |
Why?
| | Cholera Toxin | 1 | 2009 | 16 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 5604 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2005 | 767 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 980 | 0.080 |
Why?
| | Quinones | 2 | 2006 | 11 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2008 | 131 | 0.080 |
Why?
| | Ubiquitin | 1 | 2008 | 51 | 0.080 |
Why?
| | Signal Transduction | 1 | 2015 | 1753 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 259 | 0.080 |
Why?
| | Peptide Nucleic Acids | 1 | 2006 | 17 | 0.070 |
Why?
| | Mice | 3 | 2023 | 6413 | 0.070 |
Why?
| | Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2005 | 1 | 0.070 |
Why?
| | Actin-Related Protein 2-3 Complex | 1 | 2005 | 2 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 3935 | 0.060 |
Why?
| | Liver | 2 | 2022 | 1225 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2009 | 454 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2004 | 9 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2004 | 15 | 0.060 |
Why?
| | Chromatography, Affinity | 1 | 2004 | 50 | 0.060 |
Why?
| | Biosensing Techniques | 1 | 2004 | 28 | 0.060 |
Why?
| | Proteins | 1 | 2007 | 376 | 0.060 |
Why?
| | Animals | 4 | 2023 | 14385 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 382 | 0.060 |
Why?
| | Social Class | 1 | 2023 | 110 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 116 | 0.050 |
Why?
| | Resuscitation | 1 | 2022 | 83 | 0.050 |
Why?
| | Protein Binding | 3 | 2009 | 736 | 0.050 |
Why?
| | Waiting Lists | 1 | 2021 | 49 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 180 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 99 | 0.050 |
Why?
| | Transcription Factors | 1 | 2005 | 622 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2022 | 138 | 0.050 |
Why?
| | Mice, SCID | 1 | 2021 | 196 | 0.050 |
Why?
| | Brain Death | 1 | 2021 | 15 | 0.050 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 642 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2021 | 74 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2021 | 117 | 0.050 |
Why?
| | Trauma Centers | 1 | 2022 | 218 | 0.050 |
Why?
| | Hemorrhage | 1 | 2022 | 208 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2022 | 531 | 0.050 |
Why?
| | Healthcare Disparities | 1 | 2023 | 271 | 0.050 |
Why?
| | Nitriles | 1 | 2020 | 69 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2021 | 418 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 110 | 0.040 |
Why?
| | Incidence | 1 | 2022 | 1082 | 0.040 |
Why?
| | Primary Graft Dysfunction | 1 | 2018 | 3 | 0.040 |
Why?
| | Pyrimidines | 1 | 2020 | 196 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2018 | 43 | 0.040 |
Why?
| | Registries | 1 | 2021 | 553 | 0.040 |
Why?
| | Hyperkalemia | 1 | 2018 | 11 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2018 | 59 | 0.040 |
Why?
| | Length of Stay | 1 | 2021 | 683 | 0.040 |
Why?
| | Acidosis | 1 | 2018 | 38 | 0.040 |
Why?
| | Decision Support Techniques | 1 | 2018 | 74 | 0.040 |
Why?
| | Cytokines | 1 | 2021 | 676 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2021 | 546 | 0.040 |
Why?
| | Perioperative Care | 1 | 2018 | 42 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2018 | 138 | 0.040 |
Why?
| | Propensity Score | 1 | 2018 | 137 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1048 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 1999 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2021 | 1639 | 0.030 |
Why?
| | Adult | 2 | 2021 | 14207 | 0.030 |
Why?
| | Risk Assessment | 1 | 2018 | 1361 | 0.030 |
Why?
| | Cohort Studies | 1 | 2018 | 1543 | 0.030 |
Why?
| | Kidney | 1 | 2018 | 820 | 0.030 |
Why?
| | Prognosis | 1 | 2018 | 2118 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2018 | 2387 | 0.030 |
Why?
| | Time Factors | 1 | 2018 | 3213 | 0.030 |
Why?
| | Peptide Library | 1 | 2009 | 29 | 0.020 |
Why?
| | Protein Subunits | 1 | 2009 | 85 | 0.020 |
Why?
| | Ligands | 1 | 2009 | 230 | 0.020 |
Why?
| | Hydrolysis | 1 | 2008 | 68 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2008 | 80 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 105 | 0.020 |
Why?
| | Models, Chemical | 1 | 2008 | 65 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 90 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 291 | 0.020 |
Why?
| | Escherichia coli | 1 | 2009 | 250 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 218 | 0.020 |
Why?
| | Molecular Structure | 1 | 2007 | 319 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 79 | 0.020 |
Why?
| | Actin-Related Protein 3 | 1 | 2005 | 1 | 0.020 |
Why?
| | Photochemistry | 1 | 2005 | 21 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 34 | 0.020 |
Why?
| | Cell Line | 1 | 2009 | 1153 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 57 | 0.020 |
Why?
| | Cattle | 1 | 2005 | 224 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2006 | 377 | 0.020 |
Why?
| | Amino Acids | 1 | 2006 | 369 | 0.020 |
Why?
| | Binding Sites | 1 | 2005 | 440 | 0.020 |
Why?
| | Models, Molecular | 1 | 2005 | 423 | 0.020 |
Why?
| | Mutation | 1 | 2007 | 1501 | 0.010 |
Why?
|
|
Burdine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|